Ahmed, Q. A., Y. M. Arabi, and Z. A. Memish. 2006. Health risks at the Hajj. The Lancet 367(9515):1008–1015.
Aimone, F. 2010. The 1918 influenza epidemic in New York City: A review of the public health response. Public Health Reports (Washington, DC:1974) 125(Suppl 3):71–79.
Ajao, A., S. Nystrom, L. Koonin, A. Patel, D. Howell, P. Baccam, T. Lant, E. Malatino, M. Chamberlin, and M. I. Meltzer. 2015. Assessing the capacity of the US health care system to use additional mechanical ventilators during a large-scale public health emergency. Disaster Medicine and Public Health Preparedness 9(6):643–641. https://doi.org/10.1017/dmp.2015.105 (accessed April 16, 2019).
Al-Muharrmi, Z. 2010. Understanding the influenza A H1N1 2009 pandemic. Sultan Qaboos University Medical Journal 10(2):187–195.
Ali, S. T., B. J. Cowling, E. H. Y. Lau, V. J. Fang, and G. M. Leung. 2018. Mitigation of influenza B epidemic with school closures, Hong Kong, 2018. Emerging Infectious Diseases 24(11):2071–2073.
Alshukairi, A. N., J. Zheng, J. Zhao, A. Nehdi, S. A. Baharoon, L. Layqah, A. Bokhari, S. M. Al Johani, N. Samman, M. Boudjelal, P. Ten Eyck, M. A. Al-Mozaini, J. Zhao, S. Perl-man, and A. N. Alagaili. 2018. High prevalence of MERS-CoV infection in camel workers in Saudi Arabia. American Society for Microbiology 9(5):e01985–18.
APHA (American Public Health Association). 2006. Preparing for pandemic influenza. Policy 20063.
Barry, J. M. 2005. The great influenza: The epic story of the deadliest plague in history. New York: Penguin Group.
Basler, C. F., A. H. Reid, J. K. Dybing, T. A. Janczewski, T. G. Fanning, H. Zheng, M. Salvatore, M. L. Perdue, D. E. Swayne, A. García-Sastre, P. Palese, and J. K. Taubenberger. 2001. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proceedings of the National Academy of Sciences of the United States of America 98(5):2746–2751.
Bowman, A. S., S. W. Nelson, S. L. Page, J. M. Nolting, M. L. Killian, S. Sreevatsan, and R. D. Slemons. 2014. Swine-to-human transmission of influenza A (H3N2) virus at agricultural fairs, Ohio, USA, 2012. Emerging Infectious Diseases 20(9).
Brady, B. R., and H. M. Bahr. 2014. The influenza epidemic of 1918–1920 among the Navajos: Marginality, mortality, and the implications of some neglected eyewitness accounts. The American Indian Quarterly 38:459–491.
Branswell, H. 2017. As bird flu spreads, US concludes its vaccine doesn’t provide adequate protection. STAT, March 1, T20:54:11+00:00.
Bristow, N. K. 2010. It’s as bad as anything can be: Patients, identity, and the influenza pandemic. Public Health Reports 125(Suppl 3):134–144.
Broadbent, A. J., and K. Subbarao. 2011. Influenza virus vaccines: Lessons from the 2009 H1N1 pandemic. Current Opinion in Virology 1(4):254–262.
Byerly, C. R. 2010. The U.S. military and the influenza pandemic of 1918–1919. Public Health Reports 125(Suppl 3):82–91.
Carroll, D., P. Daszak, N. D. Wolfe, G. F. Gao, C. M. Morel, S. Morzaria, A. Pablos-Méndez, O. Tomori, and J. A. K. Mazet. 2018. The global virome project. Science 359(6378):872–874.
CBO (U.S. Congressional Budget Office). 2005. A potential influenza pandemic: Possible macroeconomic effects and policy issues. Washington, DC: U.S. Congressional Budget Office.
CDC (U.S. Centers for Disease Control and Prevention). 1997. Isolation of avian influenza A (H5N1) viruses from humans—Hong Kong, May–December 1997. Morbidity and Mortality Weekly Report 46(50):1204–1207.
CDC. 2009. Swine influenza A (H1N1) infection in two children—Southern California, March–April 2009. Atlanta, GA: U.S. Centers for Disease Control and Prevention.
CDC. 2012. First global estimates of 2009 H1N1 pandemic mortality released by CDC-led collaboration. https://www.cdc.gov/flu/spotlights/pandemic-global-estimates.htm (accessed February 26, 2019).
CDC. 2013a. Antibiotic resistance threats in the United States, 2013. Washington, DC: U.S. Department of Health and Human Services.
CDC. 2013b. CDC SARS response timeline. https://www.cdc.gov/about/history/sars/timeline.htm (accessed February 26, 2019).
CDC. 2014. Ebola virus disease outbreak—West Africa, September 2014. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6339a4.htm (accessed February 26, 2019).
CDC. 2018a. CDC reported flu deaths in children exceeds seasonal high. https://www.cdc.gov/flu/spotlights/reported-flu-children-deaths.htm (accessed February 26, 2019).
CDC. 2018b. Influenza vaccination information for health care workers. https://www.cdc.gov/flu/healthcareworkers.htm (accessed March 27, 2019).
CDC. 2018c. National press conference kicks off 2018–2019 flu vaccination campaign. https://www.cdc.gov/flu/spotlights/press-conference-2018-19.htm#ref1 (accessed February 26, 2019).
CDC. 2018d. Seasonal influenza vaccine effectiveness, 2004–2018. https://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm (accessed February 26, 2019).
CDC. 2019a. 2014–2016 Ebola outbreak in West Africa. https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html (accessed March 22, 2019).
CDC. 2019b. One Health. https://www.cdc.gov/onehealth/index.html (accessed February 26, 2019).
Charu, V., G. Chowell, L. S. Palacio Mejia, S. Echevarría-Zuno, V. H. Borja-Aburto, L. Simonsen, M. A. Miller, and C. Viboud. 2011. Mortality burden of the A/H1N1 pandemic in Mexico: A comparison of deaths and years of life lost to seasonal influenza. Clinical Infectious Diseases 53(10):985–993.
Chen, Y., W. Liang, S. Yang, N. Wu, H. Gao, J. Sheng, H. Yao, J. Wo, Q. Fang, D. Cui, Y. Li, X. Yao, Y. Zhang, H. Wu, S. Zheng, H. Diao, S. Xia, Y. Zhang, K.-H. Chan, H.-W. Tsoi, J. L.-L. Teng, W. Song, P. Wang, S.-Y. Lau, M. Zheng, J. F.-W. Chan, K. K.-W. To, H. Chen, L. Li, and K.-Y. Yuen. 2013. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: Clinical analysis and characterisation of viral genome. The Lancet 381(9881):1916–1925.
CHMP (Committee for Medicinal Products for Human Use). 2008. Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application. London, UK: European Medicines Agency.
Chorba, T. 2018. Trench conflict with combatants and infectious disease. Emerging Infectious Diseases 24(11):2136–2137.
Chowell, G., S. Echevarría-Zuno, C. Viboud, L. Simonsen, J. Tamerius, M. A. Miller, and V. H. Borja-Aburto. 2011. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Medicine 8(5):e1000436.
Chowell, G., F. Abdirizak, S. Lee, J. Lee, E. Jung, H. Nishiura, and C. Viboud. 2015. Transmission characteristics of MERS and SARS in the healthcare setting: A comparative study. BMC Medicine 13:210. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0450-0 (accessed March 25, 2019).
Çiftçi, E., A. Karbuz, and T. Kendirli. 2016. Influenza and the use of oseltamivir in children. Turkish Archives of Pediatrics 51(2):63–71.
Cillóniz, C., K. Shinya, X. Peng, M. J. Korth, S. C. Proll, L. D. Aicher, V. S. Carter, J. H. Chang, D. Kobasa, F. Feldmann, J. E. Strong, H. Feldmann, Y. Kawaoka, and M. G. Katze. 2009. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathogens 5(10):e1000604.
Cooper, M. 2014. China’s Pearl River Delta: Tying 11 cities into a megaregion. Urban Land Magazine. https://urbanland.uli.org/industry-sectors/infrastructure-transit/chinas-pearl-river-delta (accessed February 26, 2019).
Cowling, B. J., E. H. Y. Lau, C. L. H. Lam, C. K. Y. Cheng, J. Kovar, K. H. Chan, J. S. M. Peiris, and G. M. Leung. 2008. Effects of school closures, 2008 winter influenza season, Hong Kong. Emerging Infectious Diseases 14(10):1660–1662.
Cowling, B. J., L. Jin, E. H. Y. Lau, Q. Liao, P. Wu, H. Jiang, T. K. Tsang, J. Zheng, V. J. Fang, Z. Chang, M. Y. Ni, Q. Zhang, D. K. M. Ip, J. Yu, Y. Li, L. Wang, W. Tu, L. Meng, J. T. Wu, H. Luo, Q. Li, Y. Shu, Z. Li, Z. Feng, W. Yang, Y. Wang, G. M. Leung, and H. Yu. 2013. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: A population-based study of laboratory-confirmed cases. The Lancet 382(9887):129–137.
Craig, J. D., and L. Dublin. 1919. The influenza epidemic of 1918. Transactions Actuarial Society of America 20(61):134.
Crosby, A. W. 2003. America’s forgotten pandemic: The influenza of 1918. New York: Cambridge University Press.
C.S. Mott Children’s Hospital National Poll on Children’s Health. 2016. Inferiority complex? Parents rate flu lower than other vaccines. C.S. Mott Children’s Hospital 26(1):2.
C.S. Mott Children’s Hospital National Poll on Children’s Health. 2018. Do parents have selective hearing about flu vaccine for children? C.S. Mott Children’s Hospital 33(1):2. https://mottpoll.org/sites/default/files/documents/111918_FluVaccine.pdf (accessed March 26, 2019).
Dauer, C. C., and R. E. Serfling. 1961. Mortality from influenza. American Review of Respiratory Disease 83(2P2):15–28.
Dawood, F. S., A. D. Iuliano, C. Reed, M. I. Meltzer, D. K. Shay, P.-Y. Cheng, D. Bandaranayake, R. F. Breiman, W. A. Brooks, P. Buchy, D. R. Feikin, K. B. Fowler, A. Gordon, N. T. Hien, P. Horby, Q. S. Huang, M. A. Katz, A. Krishnan, R. Lal, J. M. Montgomery, K. Mølbak, R. Pebody, A. M. Presanis, H. Razuri, A. Steens, Y. O. Tinoco, J. Wallinga, H. Yu, S. Vong, J. Bresee, and M.-A. Widdowson. 2012. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. The Lancet Infectious Diseases 12(9):687–695.
Dimitrov, N., S. Goll, N. Hupert, B. Pourbohloul, and L. A. Meyers. 2009. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic (H1N1) influenza, 2009. PLoS One 6(3).
Dobson, J., R. J. Whitley, S. Pocock, and A. S. Monto. 2015. Oseltamivir treatment for influenza in adults: A meta-analysis of randomised controlled trials. The Lancet 385(9979):1729–1737.
Doshi, P. 2013. Influenza: Marketing vaccine by marketing disease. British Medical Journal 346:f3037.
Erbelding, E. J., D. J. Post, E. J. Stemmy, P. C. Roberts, A. D. Augustine, S. Ferguson, C. I. Paules, B. S. Graham, and A. S. Fauci. 2018. A universal influenza vaccine: The strategic plan for the National Institute of Allergy and Infectious Diseases. The Journal of Infectious Diseases 218(3):347–354.
Escher, K. 2017. The long shadow of the 1976 swine flu vaccine “fiasco.” Smithsonian. https://www.smithsonianmag.com/smart-news/long-shadow-1976-swine-flu-vaccine-fiasco-180961994 (accessed March 25, 2019).
Fan, V. Y., D. T. Jamison, and L. H. Summers. 2018. Pandemic risk: How large are the expected losses? Bulletin of the World Health Organization 96(2):129–134.
FAO (Food and Agriculture Organization of the United Nations). 2018. FAO H7N9 situation update—avian influenza A (H7N9) virus—FAO emergency prevention system for animal health. http://www.fao.org/ag/againfo/programmes/en/empres/h7n9/situation_update.html (accessed March 25, 2019).
FDA (U.S. Food and Drug Administration). 2007a. Guidance for industry: Clinical data needed to support the licensure of pandemic influenza vaccines.
FDA. 2007b. Guidance for industry: Clinical data needed to support the licensure of seasonal inactivated influenza vaccines.
Fouchier, R. A., T. Kuiken, M. Schutten, G. van Amerongen, G. J. van Doornum, B. G. van den Hoogen, M. Peiris, W. Lim, K. Stohr, and A. D. Osterhaus. 2003. Aetiology: Koch’s postulates fulfilled for SARS virus. Nature 423(6937):240.
Francis, T. 1960. On the doctrine of original antigenic sin. Proceedings of the American Philosophical Society 104(6):572–578.
Freidl, G. S., A. Meijer, E. de Bruin, M. de Nardi, O. Munoz, I. Capua, A. C. Breed, K. Harris, A. Hill, R. Kosmider, J. Banks, S. von Dobschuetz, K. Stark, B. Wieland, K. Stevens, S. van der Werf, V. Enouf, K. van der Meulen, K. Van Reeth, G. Dauphin, M. Koopmans, and F. Consortium. 2014. Influenza at the animal–human interface: A review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A (H5N1). Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles (European Communicable Disease Bulletin) 19(18):pii=20793.
Garrett, L. 1994. The coming plague: Newly emerging diseases in a world out of balance. New York: Farrar, Straus and Giroux.
Garrett, L. 2005. The next pandemic? Foreign Affairs 84(4):3–23.
Garrett, L., and R. Holbrooke. 2008. “Sovereignty” that risks global health. The Washington Post, August 10.
GHRF Commission (Commission on a Global Health Risk Framework). 2016. The neglected dimension of global security: A framework to counter infectious disease crises. Washington, DC: The National Academies Press.
Gostin, L. O. 2016. Global health security after Ebola: Four global commissions. The Milbank Quarterly 94(1):34–38.
Hajjar, S. A., Z. A. Memish, and K. McIntosh. 2013. Middle East respiratory syndrome coronavirus (MERS-CoV): A perpetual challenge. The Annals of Saudi Medicine 33(5):427–436.
Hatami, H. 2016. History of influenza: Pandemics in Iran and the world. International Journal of Infection 3(4):e36672.
Herfst, S., E. J. A. Schrauwen, M. Linster, S. Chutinimitkul, E. de Wit, V. J. Munster, E. M. Sorrell, T. M. Bestebroer, D. F. Burke, D. J. Smith, G. F. Rimmelzwaan, A. D. M. E. Osterhaus, and R. A. M. Fouchier. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336(6088):1534–1541.
Heymann, D. L., L. Chen, K. Takemi, D. P. Fidler, J. W. Tappero, M. J. Thomas, T. A. Kenyon, T. R. Frieden, D. Yach, S. Nishtar, A. Kalache, P. L. Olliaro, P. Horby, E. Torreele, L. O. Gostin, M. Ndomondo-Sigonda, D. Carpenter, S. Rushton, L. Lillywhite, B. Devkota, K. Koser, R. Yates, R. S. Dhillon, and R. P. Rannan-Eliya. 2015. Global health security: The wider lessons from the West African Ebola virus disease epidemic. The Lancet 385(9980):1884–1901.
HHS (U.S. Department of Health and Human Services). 2012. An HHS retrospective on the 2009 H1N1 influenza pandemic to advance all hazards preparedness. Washington, DC: U.S. Department of Health and Human Services.
HHS. 2017. Pandemic influenza plan. Washington, DC: U.S. Department of Health and Human Services.
HHS. 2019. Fill finish manufacturing network (FFMN). https://www.medicalcountermeasures.gov/barda/core-services/fill-finish-manufacturing-network.aspx (accessed February 26, 2019).
HKU (The University of Hong Kong). 2019. World Health Organization (WHO) H5 reference laboratory. https://www.med.hku.hk/research/research-achievements/commitmentto-global-health-and-contribution-to-the-society/world-health-organization-who-h5reference-laboratory (accessed February 26, 2019).
Hu, Y., S. Lu, Z. Song, W. Wang, P. Hao, J. Li, X. Zhang, H.-L. Yen, B. Shi, T. Li, W. Guan, L. Xu, Y. Liu, S. Wang, X. Zhang, D. Tian, Z. Zhu, J. He, K. Huang, H. Chen, L. Zheng, X. Li, J. Ping, B. Kang, X. Xi, L. Zha, Y. Li, Z. Zhang, M. Peiris, and Z. Yuan. 2013. Association between adverse clinical outcome in human disease caused by novel influenza a H7N9 virus and sustained viral shedding and emergence of antiviral resistance. The Lancet 381(9885):2273–2279.
Imai, M., T. Watanabe, M. Hatta, S. C. Das, M. Ozawa, K. Shinya, G. Zhong, A. Hanson, H. Katsura, S. Watanabe, C. Li, E. Kawakami, S. Yamada, M. Kiso, Y. Suzuki, E. A. Maher, G. Neumann, and Y. Kawaoka. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486(7403):420–428.
Imai, M., T. Watanabe, M. Kiso, N. Nakajima, S. Yamayoshi, K. Iwatsuki-Horimoto, M. Hatta, S. Yamada, M. Ito, Y. Sakai-Tagawa, M. Shirakura, E. Takashita, S. Fujisaki, R. McBride, A. J. Thompson, K. Takahashi, T. Maemura, H. Mitake, S. Chiba, G. Zhong, S. Fan, K. Oishi, A. Yasuhara, K. Takada, T. Nakao, S. Fukuyama, M. Yamashita, T. J. S. Lopes, G. Neumann, T. Odagiri, S. Watanabe, Y. Shu, J. C. Paulson, H. Hasegawa, and Y. Kawaoka. 2017. A highly pathogenic avian H7N9 influenza virus isolated from a human is lethal in some ferrets infected via respiratory droplets. Cell Host & Microbe 22(5):615–626.
Jackson, C., P. Mangtani, J. Hawker, B. Olowokure, and E. Vynnycky. 2014. The effects of school closures on influenza outbreaks and pandemics: Systematic review of simulation studies. PLoS One 9(5):e97297.
Jhung, M. A., D. Swerdlow, S. J. Olsen, D. Jernigan, M. Biggerstaff, L. Kamimoto, K. Kniss, C. Reed, A. Fry, L. Brammer, J. Gindler, W. J. Gregg, J. Bresee, and L. Finelli. 2011. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clinical Infectious Diseases 52(Suppl 1):S13–S26.
Johnson, N. P. A. S., and J. Mueller. 2002. Updating the accounts: Global mortality of the 1918–1920 “Spanish” influenza pandemic. Bulletin of the History of Medicine 76(1):105–115.
Jones, K. E., N. G. Patel, M. A. Levy, A. Storeygard, D. Balk, J. L. Gittleman, and P. Daszak. 2008. Global trends in emerging infectious diseases. Nature 451(7181):990–993.
Jordan, E. O. 1927. Epidemic influenza: A survey. Chicago, IL: American Medical Association.
Jordan, Jr., W. S. 1961. The mechanism of spread of Asian influenza. American Review of Respiratory Disease 83(2P2):29–40.
Kaufmann, S. H. E., A. Dorhoi, R. S. Hotchkiss, and R. Bartenschlager. 2017. Host-directed therapies for bacterial and viral infections. Nature Reviews Drug Discovery 17(1):35–56.
Keogh-Brown, M. R., R. D. Smith, J. W. Edmunds, and P. Beutels. 2010. The macroeconomic impact of pandemic influenza: Estimates from models of the United Kingdom, France, Belgium and the Netherlands. The European Journal of Health Economics 11(6):543–554.
Khan, K., R. Eckhardt, J. S. Brownstein, R. Naqvi, W. Hu, D. Kossowsky, D. Scales, J. Arino, M. MacDonald, J. Wang, J. Sears, and M. S. Cetron. 2013. Entry and exit screening of airline travellers during the A(H1N1) 2009 pandemic: A retrospective evaluation. Bulletin of the World Health Organization 91:368–376.
Kuiken, T., R. A. M. Fouchier, M. Schutten, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, J. D. Laman, T. de Jong, G. van Doornum, W. Lim, A. E. Ling, P. K. S. Chan, J. S. Tam, M. C. Zambon, R. Gopal, C. Drosten, S. van der Werf, N. Escriou, J.-C. Manuguerra, K. Stöhr, J. S. M. Peiris, and A. D. M. E. Osterhaus. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. The Lancet 362(9380):263–270.
Kumar, A., R. Zarychanski, R. Pinto, D. J. Cook, J. Marshall, J. Lacroix, T. Stelfox, S. Bagshaw, K. Choong, F. Lamontagne, A. F. Turgeon, S. Lapinsky, S. P. Ahern, O. Smith, F. Siddiqui, P. Jouvet, K. Khwaja, L. McIntyre, K. Menon, J. Hutchison, D. Hornstein, A. Joffe, F. Lauzier, J. Singh, T. Karachi, K. Wiebe, K. Olafson, C. Ramsey, S. Sharma, P. Dodek, M. Meade, R. Hall, R. A. Fowler, and Canadian Critical Care Trials Group H1N1 Collaborative. 2009. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. The Journal of the American Medical Association 302(17):1872–1879.
Langmuir, A. D. 1961. Epidemiology of Asian influenza. With special emphasis on the United States. American Review of Respiratory Disease 83(2P2):2–14.
Lau, M. S. Y., B. D. Dalziel, S. Funk, A. McClelland, A. Tiffany, S. Riley, C. J. E. Metcalf, and B. T. Grenfell. 2017. Spatial and temporal dynamics of superspreading events in the 2014–2015 West Africa Ebola epidemic. PNAS: Proceedings of the National Academies of Sciences of the United States of America 114(9):2337–2342.
Lipsitch, M., T. Cohen, B. Cooper, J. M. Robins, S. Ma, L. James, G. Gopalakrishna, S. K. Chew, C. C. Tan, M. H. Samore, D. Fisman, and M. Murray. 2003. Transmission dynamics and control of severe acute respiratory syndrome. Science 300(5627):1966–1970.
Lister, S. A. 2007. Pandemic influenza: Appropriations for public health preparedness and response. CRS Report for Congress. Washington, DC: Congressional Research Service, Library of Congress.
Louie, J. K., M. Acosta, D. J. Jamieson, M. A. Honein, and California Pandemic Working Group. 2010. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. New England Journal of Medicine 362(1):27–35.
MacGregor, B. 2018. Testimony to the U.S. Senate Health, Education, Labor and Pensions Committee. Facing 21st century public health threats: Our nation’s preparedness and response capabilities, part 22018. January 23.
Madhav N., B. Oppenheim, M. Gallivan, P. Mulembakani, E. Rubin, and N. Wolfe. 2017. Chapter 17: Pandemics: Risks, impacts, and mitigation. In Disease control priorities: Improving health and reducing poverty, 3rd ed., edited by D. T. Jamison, H. Gelband, and S. Horton. Washington, DC: The International Bank for Reconstruction and Development.
Mamelund, S. E. 2011. Geography may explain adult mortality from the 1918–20 influenza pandemic, epidemics. Infection Control Today 3(1):46–60. https://www.infectioncontroltoday.com/infections/1918-flu-pandemic-mortality-urban-and-isolatedrural-areas-varied (accessed March 26, 2019).
McDevitt, J. J., S. N. Rudnick, and L. J. Radonovich. 2012. Aerosol susceptibility of influenza virus to UV-C light. Applied and Environmental Microbiology 78(6):1666–1669.
McLean, K. A., S. Goldin, C. Nannei, E. Sparrow, and G. Torelli. 2016. The 2015 global production capacity of seasonal and pandemic influenza vaccine. Vaccine 34(45):5410–5413.
McLeod, M. A., M. Baker, N. Wilson, H. Kelly, T. Kiedrzynski, and J. L. Kool. 2008. Protective effect of maritime quarantine in South Pacific jurisdictions, 1918–19 influenza pandemic. Emerging Infectious Diseases 14(3):468–470.
Mishra, A. C., M. S. Chadha, M. L. Choudhary, and V. A. Potdar. 2010. Pandemic influenza (H1N1) 2009 is associated with severe disease in India. PLoS One 5(5):e10540.
Monto, A. S. 1987. Influenza: Quantifying morbidity and mortality. The American Journal of Medicine 82(6A):20–25.
Moon, S., D. Sridhar, M. A. Pate, A. K. Jha, C. Clinton, S. Delaunay, V. Edwin, M. Fallah, D. P. Fidler, L. Garrett, E. Goosby, L. O. Gostin, D. L. Heymann, K. Lee, G. M. Leung, J. S. Morrison, J. Saavedra, M. Tanner, J. A. Leigh, B. Hawkins, L. R. Woskie, and P. Piot. 2015. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM independent panel on the global response to Ebola. The Lancet 386(10009):2204–2221.
Moon, S., J. Leigh, L. Woskie, F. Checchi, V. Dzau, M. Fallah, G. Fitzgerald, L. Garrett, L. Gostin, D. L. Heymann, R. Katz, I. Kickbusch, J. S. Morrison, P. Piot, P. Sands, D. Sridhar, and A. K. Jha. 2017. Post-Ebola reforms: Ample analysis, inadequate action. British Medical Journal 356:j280.
Morse, S. S., J. A. K. Mazet, M. Woolhouse, C. R. Parrish, D. Carroll, W. B. Karesh, C. Zambrana-Torrelio, W. I. Lipkin, and P. Daszak. 2012. Prediction and prevention of the next pandemic zoonosis. The Lancet 380(9857):1956–1965.
Mougel, N. 2011. World War I Casualties. In REPERES, Module 1-1-1: Explanatory Notes, edited by Robert Schuman European Centre, European Network for Education and Training, Centre Virtuel de la Connaissance sur l’Europe Luxembourg, Maison de l’Europe Toulouse Midi-Pyrénées and The Europe House of Rhodes. http://www.centre-robert-schuman.org/userfiles/files/REPERES%20%E2%80%93%20module%201-1-1%20-%20explanatory%20notes%20%E2%80%93%20World%20War%20I%20casualties%20%E2%80%93%20EN.pdf (accessed March 26, 2019).
Mukherjee, S. 2017. Emerging infectious diseases: Epidemiological perspective. Indian Journal of Dermatology 62(5):459–467.
Murray, C. J. L., A. D. Lopez, B. Chin, D. Feehan, and K. H. Hill. 2006. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: A quantitative analysis. The Lancet 368(9554):2211–2218.
Murray, R. 1961. Some problems in the standardization and control of influenza vaccine in 1957. American Review of Respiratory Disease 83(2P2):160–167.
Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proceedings of the National Academy of Sciences of the United States of America 96(16):9345–9350.
Newman, A. P., E. Reisdorf, J. Beinemann, T. M. Uyeki, A. Balish, B. Shu, S. Lindstrom, J. Achenbach, C. Smith, and J. P. Davis. 2008. Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin. Emerging Infectious Diseases 14(9):1470–1472.
Nguyen-Van-Tam, J. S., and A. W. Hampson. 2003. The epidemiology and clinical impact of pandemic influenza. Vaccine 21(16):1762–1768.
NIAID (National Institute of Allergy and Infectious Diseases). 2017. Ebola: New trial launched in West Africa to evaluate three vaccination strategies. https://www.niaid.nih.gov/news-events/ebola-new-trial-launched-west-africa-evaluate-three-vaccinationstrategies (accessed February 26, 2019).
Nouvellet, P., T. Garske, H. L. Mills, G. Nedjati-Gilani, W. Hinsley, I. M. Blake, M. D. Van Kerkhove, A. Cori, I. Dorigatti, T. Jombart, S. Riley, C. Fraser, C. A. Donnelly, and N. M. Ferguson. 2015. The role of rapid diagnostics in managing Ebola epidemics. Nature 528(7580):S109–S116.
NPHIL (National Public Health Institute of Liberia). 2017. 2017 Annual Integrated Disease Surveillance and Response (IDSR) bulletin. Monrovia, Liberia: National Public Health Institute of Liberia.
Nyenswah, T. G., F. Kateh, L. Bawo, M. Massaquoi, M. Gbanyan, M. Fallah, T. K. Nagbe, K. K. Karsor, C. S. Wesseh, S. Sieh, A. Gasasira, P. Graaff, L. Hensley, H. Rosling, T. Lo, S. K. Pillai, N. Gupta, J. M. Montgomery, R. L. Ransom, D. Williams, A. S. Laney, K. A. Lindblade, L. Slutsker, J. L. Telfer, A. Christie, F. Mahoney, and K. M. De Cock. 2016. Ebola and its control in Liberia, 2014–2015. Emerging Infectious Diseases 22(2):169–177.
Patterson, K. D. 1986. Pandemic influenza, 1700–1900: A study in historical epidemiology. Lanham, MD: Rowman & Littlefield.
Paules, C. I., and A. S. Fauci. 2018. We need a universal flu vaccine before the next pandemic strikes. Scientific American. https://www.scientificamerican.com/article/we-need-a-universal-flu-vaccine-before-the-next-pandemic-strikes (accessed March 25, 2019).
Paules, C. I., H. D. Marston, R. W. Eisinger, D. Baltimore, and A. S. Fauci. 2017. The pathway to a universal influenza vaccine. Immunity 47(4):599–603.
Paules, C. I., S. G. Sullivan, K. Subbarao, and A. S. Fauci. 2018. Chasing seasonal influenza—The need for a universal influenza vaccine. New England Journal of Medicine 378(1):7–9.
Peiris, J. S. M., B. J. Cowling, J. T. Wu, L. Feng, Y. Guan, H. Yu, and G. M. Leung. 2016. Interventions to reduce zoonotic and pandemic risks from avian influenza in Asia. The Lancet Infectious Diseases 16(2):252–258.
Poloczanska, E. S., C. J. Brown, W. J. Sydeman, W. Kiessling, D. S. Schoeman, P. J. Moore, K. Brander, J. F. Bruno, L. B. Buckley, M. T. Burrows, C. M. Duarte, B. S. Halpern, J. Holding, C. V. Kappel, M. I. O’Connor, J. M. Pandolfi, C. Parmesan, F. Schwing, S. A. Thompson, and A. J. Richardson. 2013. Global imprint of climate change on marine life. Nature Climate Change 3:919–925.
Prager, F., D. Wei, and A. Rose. 2017. Total economic consequences of an influenza outbreak in the United States. Risk Analysis 37(1):4–19.
Reid, A. H., T. G. Fanning, J. V. Hultin, and J. K. Taubenberger. 1999. Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene. Proceedings of the National Academy of Sciences of the United States of America 96(4):1651–1656.
Reid, A. H., T. G. Fanning, T. A. Janczewski, and J. K. Taubenberger. 2000. Characterization of the 1918 “Spanish” influenza virus neuraminidase gene. Proceedings of the National Academy of Sciences of the United States of America 97(12):6785–6790.
Reid, A. H., T. G. Fanning, T. A. Janczewski, S. McCall, and J. K. Taubenberger. 2002. Characterization of the 1918 “Spanish” influenza virus matrix gene segment. Journal of Virology 76(21):10717–10723.
Reid, A. H., T. G. Fanning, T. A. Janczewski, R. M. Lourens, and J. K. Taubenberger. 2004. Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. Journal of Virology 78(22):12462–12470.
Rice, G. W. 2016. Black November: The 1918 Influenza Pandemic in New Zealand. Christchurch, New Zealand: Canterbury University Press.
Roberts, D. 1919. The unidentified pandemic disease (influenza?). The American Journal of Medical Sciences 158:397–406.
Russell, R. J., P. S. Kerry, D. J. Stevens, D. A. Steinhauer, S. R. Martin, S. J. Gamblin, and J. J. Skehel. 2008. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proceedings of the National Academy of Sciences of the United States of America 105(46):17736–17741.
Schwerdtle, P., V. De Clerck, and V. Plummer. 2017. Survivors’ perceptions of public health messages during an Ebola crisis in Liberia and Sierra Leone: An exploratory study. Nursing & Health Sciences 19(4):492–497.
Shi, J., G. Deng, S. Ma, X. Zeng, X. Yin, M. Li, B. Zhang, P. Cui, Y. Chen, H. Yang, X. Wan, L. Liu, P. Chen, Y. Jiang, Y. Guan, J. Liu, W. Gu, S. Han, Y. Song, L. Liang, Z. Qu, Y. Hou, X. Wang, H. Bao, G. Tian, Y. Li, L. Jiang, C. Li, and H. Chen. 2018. Rapid evolution of H7N9 highly pathogenic viruses that emerged in China in 2017. Cell Host & Microbe 24(4):558–568.
Simonsen, L., P. Spreeuwenberg, R. Lustig, R. J. Taylor, D. M. Fleming, M. Kroneman, M. D. Van Kerkhove, A. W. Mounts, W. J. Paget, and G. L. C. Teams. 2013. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: A modeling study. PLoS Medicine 10(11):e1001558.
Smith, R. D. 2006. Responding to global infectious disease outbreaks: Lessons from SARS on the role of risk perception, communication and management. Social Science & Medicine 63(12):3113–3123.
Supari, S. F. 2008. It’s time for the world to change: In the spirit of dignity, equity, and transparency: Divine hand behind avian influenza. Jakarta, Indonesia: Sulaksana Watinsa.
Taubenberger, J. K., A. H. Reid, A. E. Krafft, K. E. Bijwaard, and T. G. Fanning. 1997. Initial genetic characterization of the 1918 “Spanish” influenza virus. Science 275(5307):1793–1796.
Taubenberger, J. K., A. H. Reid, R. M. Lourens, R. Wang, G. Jin, and T. G. Fanning. 2005. Characterization of the 1918 influenza virus polymerase genes. Nature 437(7060): 889–893.
UN (United Nations). 2016. Protecting humanity from future health crises: Report of the high-level panel on the global response to health crises. New York: United Nations.
UNAIDS (Joint United Nations Programme on HIV/AIDS). 2018. PEPFAR: The first 15 years. http://www.unaids.org/en/resources/presscentre/featurestories/2018/september/pepfar-the-first-15-years (accessed February 26, 2019).
UNICEF (United Nations Children’s Fund). 2013. At a glance: Sierra Leone. https://www.unicef.org/infobycountry/sierraleone_statistics.html (accessed February 26, 2019).
University of Michigan Center for the History of Medicine. 2016. San Francisco, California, and the 1918–1919 Influenza Epidemic. In The American influenza epidemic of 1918: A digital encyclopedia, 2nd edition. Produced by the University of Michigan Center for the History of Medicine and Michigan Publishing, University of Michigan Library. https://www.influenzaarchive.org/cities/city-sanfrancisco.html# (accessed March 26, 2019).
UNWTO (United Nations World Tourism Organization). 2018. International tourist arrivals. https://stats.areppim.com/stats/stats_ita.htm (accessed February 26, 2019).
USDA (U.S. Department of Agriculture) Foreign Agricultural Service. 2017. Hong Kong exporter guide 2017. Washington, DC: U.S. Department of Agriculture.
USG (U.S. Government). 2018. National biodefense strategy. Washington, DC: U.S. Executive Office of the President.
Virchow, R. C. 2006. Report on the typhus epidemic in Upper Silesia. 1848. American Journal of Public Health 96(12):2102–2105.
Vital Strategies. 2018. Most countries aren’t prepared for the next epidemic. New York: Vital Strategies.
Watanabe, S., B. R. Rost, M. Camacho-Pérez, M. W. Davis, B. Söhl-Kielczynski, C. Rosenmund, and E. M. Jorgensen. 2013. Ultrafast endocytosis at mouse hippocampal synapses. Nature 504(7479):242–247.
Weir, J. P., and M. F. Gruber. 2016. An overview of the regulation of influenza vaccines in the United States. Influenza and Other Respiratory Viruses 10(5):354–360.
WHO (World Health Organization). 2006. Constitution of the World Health Organization. Geneva, Switzerland: World Health Organization.
WHO. 2007a. Proposes guidelines: Regulatory preparedness for human pandemic influenza vaccine. https://www.who.int/biologicals/publications/trs/areas/vaccines/influenza/Human_pandemic_Influenza_Vaccines_BS2074_01Feb08.pdf (access March 25, 2019).
WHO. 2007b. WHA60.28 pandemic influenza preparedness: Sharing of influenza viruses and access to vaccines and other benefits. Geneva, Switzerland: World Health Organization.
WHO. 2009a. Current WHO phase of pandemic alert for pandemic (H1N1) 2009. https://www.who.int/csr/disease/swineflu/phase/en (accessed February 26, 2019).
WHO. 2009b. Influenza A (H1N1)—update 5. https://www.who.int/csr/don/2009_04_29/en (accessed March 26, 2019).
WHO. 2011. Strengthening response to pandemics and other public-health emergencies: Report of the review committee on the functioning of the International Health Regulations (2005) and on pandemic influenza (H1N1) 2009. Geneva, Switzerland: World Health Organization.
WHO. 2012. Report of the WHO pandemic influenza A (H1N1) vaccine deployment initiative. Geneva, Switzerland: World Health Organization.
WHO. 2014. H5N1 highly pathogenic avian influenza: Timeline of major events. Geneva, Switzerland: World Health Organization.
WHO. 2015. WHO emergency use assessment and listing procedures for medical products during public health emergencies. https://www.who.int/medicines/news/public_consult_med_prods/en (accessed February 26, 2019).
WHO. 2016a. Meeting of the Pandemic Influenza Preparedness Framework advisory group, 18–21 October 2016, Geneva, Switzerland: Report to the Director-General. Geneva, Switzerland: World Health Organization.
WHO. 2016b. WHO’s high-level mission to Saudi Arabia on Middle East respiratory syndrome coronavirus (MERS-CoV) 11–14 January 2016. Geneva, Switzerland: World Health Organization.
WHO. 2016c. Zika situation report: Neurological syndrome and congenital anomalies, 5 February 2016. Geneva, Switzerland: World Health Organization.
WHO. 2017a. Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj). https://www.who.int/ith/updates/20170408/en (accessed February 26, 2019).
WHO. 2017b. Pandemic Influenza Preparedness Framework (“PIP Framework”) advisory group annual report to the Director-General under PIP Framework section 7.2.5. Geneva, Switzerland: World Health Organization.
WHO. 2018a. Available candidate vaccine viruses and potency testing reagents. https://www.who.int/influenza/vaccines/virus/candidates_reagents/home/en (accessed February 26, 2019).
WHO. 2018b. Ebola virus disease—Democratic Republic of the Congo. https://www.who.int/csr/don/29-november-2018-ebola-drc/en (accessed February 26, 2019).
WHO. 2018c. High levels of antibiotic resistance found worldwide, new data shows. Geneva, Switzerland: World Health Organization.
WHO. 2018d. HIV/AIDS. https://www.who.int/news-room/fact-sheets/detail/hiv-aids (accessed February 26, 2019).
WHO. 2018e. Partnership contribution collection. https://www.who.int/influenza/pip/benefit_sharing/pc_collection/en (accessed February 26, 2019).
WHO. 2019a. About WHO prequalification of vaccines. https://www.who.int/medicines/regulation/prequalification/prequal-vaccines/about/en (accessed February 26, 2019).
WHO. 2019b. Fact sheet: Global Influenza Surveillance and Response System (GISRS). https://www.who.int/influenza/gisrs_laboratory/updates/gisrs_one_pager/en (accessed February 26, 2019).
Wibisono, M. 2008. The responsible virus and sharing benefits. The Jakarta Post, August 27.
World Bank. 2017. Drug-resistant infections: A threat to our economic future: Final report. Washington, DC: World Bank Group.
Wu, J. T., B. J. Cowling, E. H. Y. Lau, D. K. M. Ip, L.-M. Ho, T. Tsang, S.-K. Chuang, P.-Y. Leung, S.-V. Lo, S.-H. Liu, and S. Riley. 2010. School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerging Infectious Diseases 16(3):538–541.
Xu, C., J. Wang, L. Wang, and C. Cao. 2014. Spatial pattern of severe acute respiratory syndrome in-out flow in 2003 in Mainland China. BMC Infectious Diseases 14:721.
Yu, H., B. J. Cowling, L. Feng, E. H. Y. Lau, Q. Liao, T. K. Tsang, Z. Peng, P. Wu, F. Liu, V. J. Fang, H. Zhang, M. Li, L. Zeng, Z. Xu, Z. Li, H. Luo, Q. Li, Z. Feng, B. Cao, W. Yang, J. T. Wu, Y. Wang, and G. M. Leung. 2013. Human infection with avian influenza A H7N9 virus: An assessment of clinical severity. The Lancet 382(9887):138–145.
Yu, H., J. T. Wu, B. J. Cowling, Q. Liao, V. J. Fang, S. Zhou, P. Wu, H. Zhou, E. H. Y. Lau, D. Guo, M. Y. Ni, Z. Peng, L. Feng, H. Jiang, H. Luo, Q. Li, Z. Feng, Y. Wang, W. Yang, and G. M. Leung. 2014. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: An ecological study. The Lancet 383(9916):541–548.
This page intentionally left blank.